Speaker :

Dr. M. V. Chandrakanth, Medical Oncologist, Kolkata

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in  Triple-Negative Breast Cancer

Author: Shaokun Shu 

Citation: Mol Cell. 2020 Jun 18;78(6):1096-1113.e8

Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors

Author: Johanna M. Schafer 

Citation: Science Translational Medicine 11 Mar 2020:Vol. 12, Issue 534, eaaw8275 DOI: 10.1126/scitranslmed.aaw8275